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A B S T R A C T
A woman presented with a solitary cardiac metastasis 5 months after curative surgery for endometrial
adenocarcinoma (FIGO IB). The tumor was deemed inoperable and palliative ambulatory chemotherapy
was initiated. We aimed at a palliative reduction of tumor mass after chemotherapy and atypical
vascularization of the metastasis was demonstrated by coronary angiography. We identiﬁed two tumor
vessels originating from the ramus circumﬂexus suitable to palliative percutaneous coronary
intervention. Within 5 weeks, the initially mild dyspnea increased to New York Heart Association
class III and readmission was planned. Regrettably, our patient died from congestive right heart failure
only 2 months after diagnosis of tumor recurrence. This report illustrates the need for resolute action
without delay even in cases of only mild right heart failure.
<Learning objective: Right ventricular metastasis of gynecologic cancer is a rare phenomenon and
prognosis of symptomatic patients is poor. In carefully selected patients with symptomatic disease, a
palliative percutaneous intervention is feasible and, if appropriate, should be discussed in an
interdisciplinary fashion without delay.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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A 64-year-old woman presented with swelling of her left leg
and mild dyspnea [New York Heart Association (NYHA) class II].
Her medical history consisted of a poorly differentiated adenos-
quamous carcinoma of the uterus (FIGO 1B, G3). To date, the
patient was classiﬁed disease-free 5 months after curative surgery
(hysterectomy and bilateral salpingo-oophorectomy) with post-
operative radiotherapy and denied any B symptoms.
Ultrasound revealed old iliacal deep venous thrombosis with
only mild elevation of D-dimer (1.2 mg/l). Subsequent computed
tomography detected diffuse pulmonary embolism as a probable
cause of dyspnea and, surprisingly, a large mass in the right
ventricle (RV). Echocardiography showed a nearly complete
obstruction of the dilated RV with the beginning of obstruction
of the inﬂow tract, moderate tricuspid regurgitation, developing
hepatic congestion, and ﬂoating parts of the huge intracardiac
mass (Figs. 1 and 2). Echocardiographic measured RV pressure was
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or TAPSE was 2.2 cm).
Magnetic resonance imaging showed a 6 cm  5 cm homoge-
neous mass descending from the rear wall of the RV and a cardiac
tumor, most probably a solitary cardiac metastasis, was diagnosed.
Interestingly, the electrocardiogram (sinus rhythm 82/min)
showed negative T waves in the inferior leads but no right
bundle-branch block.
We performed a diagnostic pericardiocentesis of the moderate
pericardial effusion (2 cm) of minor hemodynamic signiﬁcance
without detection of malignant cells. An ultrasound-guided
transvascular RV biopsy then veriﬁed the diagnosis of a cardiac
metastasis of the endometrial adenocarcinoma (estrogen receptor
negative, pan-cytokeratin AE1/3 and Vimentin positive, Ki 67 index
40%) with adherent thrombus formation.
The tumor was deemed inoperable given its size and the vast
involvement of the myocardium.
Tumor staging revealed advanced disease (FIGO IVB) with
suspect iliacal lymph nodes and, after discussion at the tumor
board, palliative chemotherapy with carboplatin and paclitaxel
was initiated.
In order to gain symptom relief and improve quality of life, we
aimed at a palliative reduction of tumor mass after chemotherapy.
By means of coronary angiography, atypical vascularization of the
metastasis from the surrounding coronary artery system wass reserved.
Fig. 1.
Cardiac metastasis causing nearly complete obstruction of the dilated
right ventricle, short-axis view.
Fig. 2.
Cardiac metastasis causing nearly complete obstruction of the dilated
right ventricle, apical four-chamber view.
Fig. 3. Tumor vascularization originating from the circumﬂex coronary artery.
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ramus circumﬂexus suitable for palliative percutaneous coronary
intervention, analogous to transcoronary ablation of septal hyper-
trophy (TASH) (Fig. 3). Because of the stable hemodynamic status
and the availability of this established oncologic chemotherapy we
abstained from an immediate interventional approach and intended
a reevaluation after completion of the chemotherapy cycles.Within 5 weeks, the initially mild dyspnea increased to NYHA
class III with peripheral edema, and readmission to our department
was planned. Regrettably, our patient died from congestive right
heart failure only 2 months after ﬁrst diagnosis of tumor
recurrence.
Discussion
Right ventricular metastasis is a generally rare phenomenon.
The three most common malignant neoplasms appear to be
carcinoma of the lung, esophageal carcinoma, and lymphoma [1]. A
literature search for particular metastatic spread of endometrial
adenocarcinoma to the right ventricle revealed only four cases [2–
5]. Right heart catheterization and biopsy, if necessary, should be
performed under ultrasound guidance, for fatal adverse hemody-
namic consequences have been reported [6].
The intracardiac mass may initially be asymptomatic but
subsequent obstruction of the RV outﬂow tract can swiftly
accelerate the course of the disease resulting in poor prognosis
[2,4,6].
To date, only few cases of interventional therapy of metastatic
RV obstruction are described in the literature. Valentin and Butz
reported one case each of coiling of tumor vessels (leiomyosar-
coma of the uterus and renal cell carcinoma) with an asymptom-
atic survival of over 10 and 19 months, respectively. Kotani et al.
reported a case of successful transcoronary chemoembolization for
relief of RV outﬂow obstruction derived from hepatocellular
carcinoma [7–9].
The main objective of an intervention in the case of
symptomatic obstruction is a palliative tumor-mass reduction
with concomitant reduction of RV pressure and amelioration of
congestive right heart failure.
Deﬁnitive preinterventional identiﬁcation of main tumor
feeding branches is obligatory and can be done by simple
coronary angiogram or by intracoronary contrast injection
through the balloon catheter under transesophageal echocardio-
graphic control prior to induction of the necrosis [7,8]. It remains
unclear whether chemoembolization or coiling of the tumor
vessels will lead to best results and carries the lowest risk of
complication (e.g. RV rupture). Recommended safety measures
should include periinterventional monitoring of vital function
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treatment with morphine.
Conclusion
Altogether, an interventional approach has been described as a
feasible procedure for interdisciplinary palliative therapy of
symptomatic metastatic RV obstruction and should be evaluated
early, while the natural course of symptomatic disease is rapidly
deteriorating and no time is to be lost.
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